Yahoo News: UC researchers aim to offer more cancer treatment options for patients
The American Cancer Society estimates that one in two men and one in three women will receive a cancer diagnosis at some point in their life, but cancer researchers are continuing to make advancements to improve cancer treatment options for patients.
Yahoo News and WLWT highlighted the work being done in Trisha Wise-Draper's lab at the University of Cincinnati. Wise-Draper said new treatments like immunotherapy, which helps train the body to fight cancer cells, provide more focused treatment.
"Every therapy could potentially have side effects, but the more targeted we get to the cancer, the less likely you get systemic effects," Wise-Draper, MD, associate professor of medicine in the Division of Hematology/Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader, medical director of the University of Cincinnati Cancer Center Clinical Trials Office and Lab and a UC Health physician, told WLWT.
Earlier this year, Wise-Draper published research that showed administering an immunotherapy drug to standard of care treatment regimens led to increased survival rates for patients with head and neck cancer with intermediate risk features.
Davendra Sohal, MD, associate professor of medicine, director of experimental therapeutics and clinic medical director in UC’s Division of Hematology/Oncology, University of Cincinnati Cancer Center associate director for clinical research and a UC Health physician, told WLWT that research and clinical trials are able to move forward both due to federal funding, but also through support from philanthropic organizations and the community.
Sohal and Wise-Draper will both be participating in the Ride Cincinnati fundraiser this weekend to raise money for the University of Cincinnati Cancer Center.
"Every dollar raised comes to cancer research. Cancer research cannot be funded by only one or the other component. We need all components," Sohal said.
Watch the segment on Yahoo News.
Learn more about Ride Cincinnati.
Featured photo at top of Dr. Wise-Draper courtesy of UC Health.
Related Stories
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.